HOME >> BIOLOGY >> NEWS
Staphylococcus aureus hides out in cells

A major cause of human and animal infections, Staphylococcus aureus bacteria may evade the immune systems defences and dodge antibiotics by climbing into our cells and then lying low to avoid detection. New research in the online open access journal BMC Genomics shows how S. aureus makes itself at home in human lung cells for up to two weeks.

A team of 12 researchers from University Hospital of Geneva, Switzerland and the Institute of Food Research, Norwich, UK set out to uncover what S. aureus (6850) did inside human lung epithelial cells (A549) using an in vitro model. They found that shortly after S. aureus entered the lung cells, the bacterias gene expression profile dramatically changed: gene expression for bacterial metabolic functions and transport shut down, putting the bacteria in a dormant state. Simultaneously, production of toxins potentially lethal for the epithelial cells becomes strictly controlled to limit cellular damage. Mechanisms that helped the bacteria to survive and/or multiply, including metabolic and energy production functions, then resumed. Although most of the bacteria had died by about four days as a result of antibiotic treatment, the team still found viable bacteria in their model system two weeks after infection.

The findings may help in understanding persistent infections, and in designing new antibacterial drugs. S. aureus has not traditionally been considered an intracellular pathogen, but the molecular details that govern its extended persistence remain largely unknown. The bacteria can generate relapsing infections even years after the first episode was apparently cured.

S. aureus intracellular survival appears related to its capability to adopt a discrete behaviour instead of actively duplicating, says Patrice Francois, a Geneva-based member of the research team. S. aureus then benefits from natural or programmed cell death to re-emerge and trigger another episode of infection, leading to chroni
'"/>

Contact: Charlotte Webber
press@biomedcentral.com
44-020-763-19986
BioMed Central
14-Jun-2007


Page: 1 2

Related biology news :

1. Engineered protein effective against Staphylococcus aureus toxin
2. Return of the Staphylococcus aureus superbug
3. Bedsores and bald hides: Novel roles revealed for a scaffolding protein
4. Newly created cancer stem cells could aid breast cancer research
5. ESF EURYI award winner aims to stop cancer cells reading their own DNA
6. OHSU turns mouse into factory for human liver cells
7. UCLA scientists produce functioning neurons from human embryonic stem cells
8. UCF research links proteins, stem cells and potential Alzheimers treatment
9. Teamwork between 2 key proteins necessary for normal development and regulation of red blood cells
10. In a first, Einstein scientists discover the dynamics of transcription in living mammalian cells
11. How cells change the pace of their steps

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/12/2020)... ... August 11, 2020 , ... Both Roche, based in ... into license agreements with Housey Pharma’s HMI subsidiary to gain access to its ... annual Research and Development spending in excess of US $10 billion. , Scientists ...
(Date:8/3/2020)... ... 03, 2020 , ... Accumen Inc. is helping healthcare get ... Spectrum Solutions, to provide COVID-19 saliva testing kits nationally. , “Accumen has ... than 10 years. Early in the COVID-19 crisis, we identified supply chain gaps ...
(Date:7/18/2020)... ... 2020 , ... Commercial launch readiness is a critical stage in a product ... or vaccine, the global economic downturn will only increase price pressures overall for the ... capturing full value from every product launch is critical. However, history shows that only ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... ... July 29, 2020 , ... The ... centers in 16 countries, has reached its 20th anniversary of worldwide use. Introduced ... use at top universities including University of Pennsylvania, University of Michigan, University of ...
(Date:7/18/2020)... Ohio (PRWEB) , ... July 16, 2020 , ... ... data solutions to aid in the early detection and prevention of high-burden diseases, ... to enable US-based hospitals and healthcare organizations to utilize existing data in order ...
(Date:7/10/2020)... ... July 09, 2020 , ... Sentien Biotechnologies, Inc., a clinical-stage ... Allen R. Nissenson, M.D., F.A.C.P., as its Chief Medical Officer. Dr. Nissenson ... product, SBI-101. Dr. Nissenson serves as an Emeritus Professor of Medicine at ...
(Date:7/1/2020)... WESTMINSTER, Colo. (PRWEB) , ... ... ... providers of expert tissue data insights, today announced that the launch of ... PD-L1 results along with data about the tumor microenvironment (TME). , “Flagship’s ...
Breaking Biology Technology:
Cached News: